SPR Therapeutics Inc., a Cleveland-headquartered medical device company, has been awarded two new grants and one new contract from the U.S. Department of Defense, totaling $10 million to further develop its non-opioid pain management therapy.
The therapy, SPR’s SPRINT Peripheral Nerve Stimulation (PNS) System, is FDA-cleared for the treatment of acute and chronic pain.
Click here to read the complete article.
Story excerpt provided by Crain’s Cleveland Business.
Written by Lydia Coutré.
Originally published October 3, 2018.